(Total Views: 517)
Posted On: 08/22/2020 11:22:46 AM
Post# of 653
$RLFTF Sounds like the FDA are liking the results and don't want to leave current lives at risk out..
"The FDA also granted an expanded access protocol for RLF-100 (aviptadil), from Geneva-based Relief Therapeutics Holdings AG and Radnor, Pa.-based Neurorx Inc., to those patients who are ineligible for enrollment in clinical trials" -
From the Article in Bio-World
"The FDA also granted an expanded access protocol for RLF-100 (aviptadil), from Geneva-based Relief Therapeutics Holdings AG and Radnor, Pa.-based Neurorx Inc., to those patients who are ineligible for enrollment in clinical trials" -
From the Article in Bio-World
(0)
(0)
$MJ
